| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f29a7567e9a18cb7d32d1a91cee922d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60f67cf07e3fdc9c7d98b1c36039ec12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
| filingDate |
2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15593b455a2d14b3e1ac29f706ad828c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_527a019a4c0628109508e8f0af3dfd82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ad4fc9adcbbb6c8f95f40d29aa6ab7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_721f89cc66901bd046b4ccf49d29e615 |
| publicationDate |
2020-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2794449-T3 |
| titleOfInvention |
Liquid formulation comprising a GM-CSF neutralizing compound |
| abstract |
An aqueous composition comprising: i) a GM-CSF neutralizing compound which is a human monoclonal antibody that binds to GM-CSF comprising a light chain amino acid sequence as set forth in SEQ ID NO. 34 and a heavy chain amino acid sequence as set forth in SEQ ID NO: 35, at a concentration of 100 mg / ml to 180 mg / ml, ii) 5% (w / v) sorbitol, iii) L-histidine 30 mM and iv) has a pH of 5.8. |
| priorityDate |
2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |